Greenbrook
Overview
Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar® TMS and Spravato® therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we’re expanding access to life-changing care—combining cutting-edge technology with clinical expertise to make a real impact in the mental health space. Inamdar & Sheth Professional Medical Corporation
(a division of Greenbrook TMS NeuroHealth Centers Services, LLC) OPEN ROLE:
FULL-TIME BOARD CERTIFIED & BOARD ELIGIBLE PSYCHIATRIST
FOR ON SITE TMS TREATMENT AND TO EXPAND SPRAVATO® PROGRAM IN OUR PORTLAND AND CLACKAMAS CLINICS. Greenbrook now operates 95 centers throughout the United States with a focus on specialized services for treatment-resistant depression, OCD, and other mental health disorders.
Role and Responsibilities
Provide on-site TMS treatment at Portland and Clackamas clinics.
Expand the Spravato® program in the specified clinics.
Collaborate with management and clinical leadership to support program growth and patient care.
Maintain board certification status and participate in professional development and training.
Qualifications
Board-certified or board-eligible psychiatrist.
Experience or interest in transcranial magnetic stimulation (TMS) and Spravato® therapies is implied by the role but not explicitly required beyond the on-site provision and program expansion responsibilities.
Why Join?
Expand your professional knowledge & clinical skillset
Make a difference in the lives of patients using innovative treatment options
Enjoy flexibility with respect to scheduling (no nighttime, weekend, or on call hours)
Benefit from an additional income opportunity with competitive pay
Receive specialized TMS certification and training
Work alongside our experienced management & clinical leadership team
Competitive pay
Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS) therapy, which administers local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Additionally, Greenbrook now offers the only FDA-approved ketamine-based psychedelic treatment for depression. Since inception, Greenbrook has provided more than 1.3 MILLION TMS treatments to over 40,000 patients struggling with depression.
Over 16 million Americans are affected by depression. Greenbrook TMS is changing the way that depression is treated, and YOU can be part of making a positive difference in the lives of patients by joining our amazing team!
To learn more about our WHY, click here: https://youtu.be/yrr-wlFftT0
For patient testimonies on HOW we are transforming lives for the better, click here: https://www.greenbrooktms.com/patient-stories
To access provider information, click here: https://www.greenbrookproviders.com
#J-18808-Ljbffr
Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar® TMS and Spravato® therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we’re expanding access to life-changing care—combining cutting-edge technology with clinical expertise to make a real impact in the mental health space. Inamdar & Sheth Professional Medical Corporation
(a division of Greenbrook TMS NeuroHealth Centers Services, LLC) OPEN ROLE:
FULL-TIME BOARD CERTIFIED & BOARD ELIGIBLE PSYCHIATRIST
FOR ON SITE TMS TREATMENT AND TO EXPAND SPRAVATO® PROGRAM IN OUR PORTLAND AND CLACKAMAS CLINICS. Greenbrook now operates 95 centers throughout the United States with a focus on specialized services for treatment-resistant depression, OCD, and other mental health disorders.
Role and Responsibilities
Provide on-site TMS treatment at Portland and Clackamas clinics.
Expand the Spravato® program in the specified clinics.
Collaborate with management and clinical leadership to support program growth and patient care.
Maintain board certification status and participate in professional development and training.
Qualifications
Board-certified or board-eligible psychiatrist.
Experience or interest in transcranial magnetic stimulation (TMS) and Spravato® therapies is implied by the role but not explicitly required beyond the on-site provision and program expansion responsibilities.
Why Join?
Expand your professional knowledge & clinical skillset
Make a difference in the lives of patients using innovative treatment options
Enjoy flexibility with respect to scheduling (no nighttime, weekend, or on call hours)
Benefit from an additional income opportunity with competitive pay
Receive specialized TMS certification and training
Work alongside our experienced management & clinical leadership team
Competitive pay
Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS) therapy, which administers local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Additionally, Greenbrook now offers the only FDA-approved ketamine-based psychedelic treatment for depression. Since inception, Greenbrook has provided more than 1.3 MILLION TMS treatments to over 40,000 patients struggling with depression.
Over 16 million Americans are affected by depression. Greenbrook TMS is changing the way that depression is treated, and YOU can be part of making a positive difference in the lives of patients by joining our amazing team!
To learn more about our WHY, click here: https://youtu.be/yrr-wlFftT0
For patient testimonies on HOW we are transforming lives for the better, click here: https://www.greenbrooktms.com/patient-stories
To access provider information, click here: https://www.greenbrookproviders.com
#J-18808-Ljbffr